$67.79-1.07 (-1.55%)
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
Inspire Medical Systems, Inc. in the Healthcare sector is trading at $67.79 with a market capitalization of $2.2B. Wall Street consensus targets $66.12 (16 analysts), implying a -2.5% move over the next 12 months. The stock is currently 54% below its 52-week high of $147.03, remaining 12.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $200.58Mβ | $204.58Mβ | $269.08Mβ | $224.50Mβ | $217.09M |
| Gross Profit | $171.46Mβ | $176.91Mβ | $233.01Mβ | $192.73Mβ | $182.41M |
| Operating Income | -$514,000β | -$1.12Mβ | $46.11Mβ | $9.64Mβ | -$3.32M |
| Net Income | $314,000β | -$11.29Mβ | $136.09Mβ | $9.93Mβ | -$3.59M |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers...